The results of the second randomised controlled trial (RCT) examining the efficacy of the Lenire tinnitus therapy system have now been published in the respected journal "Nature - Scientific Reports".
Demonstrating greater relief from tinnitus
TENT-A2 shows that optimizing treatment plans can result in greater reduction in tinnitus symptoms, which can be sustained for 12 months after treatment.
95% of treatment compliant participants demonstrated an improvement in tinnitus symptom severity when evaluated after 12 weeks of treatment*.
91% of treatment compliant participants experienced continued improvement in tinnitus symptom severity when evaluated at 12-months post-treatment.
87.8% of participants when asked at their final visit, said they would recommend the Lenire? treatment to others with tinnitus.
Conlon et al. Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial, Sci Rep, https://doi.org/10/10/38/s41598-022-13875-x(2022)